Heron Therapeutics Inc (STU:AXD2) Stock News, Headlines & Updates
Heron Therapeutics Inc Stock News from GuruFocus
- 1
Jun 09, 2025
Heron Therapeutics (HRTX) Receives "Buy" Initiation from HC Wainwright | HRTX Stock News
GuruFocus News • 7:00am
Heron Therapeutics (HRTX) Gains Buy Rating and Positive Outlook | HRTX Stock News
GuruFocus News • 5:31am
May 07, 2025
Heron Therapeutics Inc (HRTX) Q1 2025 Earnings Call Highlights: Record EBITDA and Significant Product Growth
GuruFocus News • 1:04am
Q1 2025 Heron Therapeutics Inc Earnings Call Transcript
GuruFocus News • 11:04pm
May 06, 2025
Heron Therapeutics (HRTX) Resolves Patent Dispute with Viatris
GuruFocus News • 10:02am
Heron Therapeutics (HRTX) Surpasses Q1 Expectations with Strong Earnings
GuruFocus News • 7:56am
Heron Therapeutics Inc (HRTX) Q1 2025 Earnings: EPS of $0.01 Beats Estimate, Revenue Surpasses Expectations at $38.9 Million
GuruFocus News • 7:12am
Heron Therapeutics (HRTX) Settles Patent Disputes with Mylan Pharmaceuticals | HRTX Stock News
GuruFocus News • 7:07am
HRTX Achieves Record Q1 Revenue, Surpassing Expectations | HRTX Stock News
GuruFocus News • 7:02am
Heron Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Corporate Updates | HRTX Stock News
GuruFocus News • 7:01am
Heron Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Corporate Updates
PRNewswire • 7:00am
Heron Therapeutics Announces Settlement with Mylan Related to CINVANTI® and APONVIE® Patent Litigations
PRNewswire • 7:00am
Heron Therapeutics Announces Settlement with Mylan Related to CINVANTI® and APONVIE® Patent Litigations | HRTX Stock News
GuruFocus News • 6:47am
May 05, 2025
Heron Therapeutics (HRTX) Awaits Q1 Earnings Report
GuruFocus News • 11:00am
Apr 28, 2025
Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer | HRTX Stock News
GuruFocus News • 6:15pm
Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer
PRNewswire • 6:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news